Cite
HARVARD Citation
Merola, J. et al. (n.d.). P279 Guselkumab was more effective than secukinumab in patients with plaque psoriasis and the subset of patients with self-reported PsA in the randomised, double-blind, head-to-head comparison study ECLIPSE over 1 year. Rheumatology. p. . [Online].